[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU5453490A - Therapeutic uses of cyanocobalamin - Google Patents

Therapeutic uses of cyanocobalamin

Info

Publication number
AU5453490A
AU5453490A AU54534/90A AU5453490A AU5453490A AU 5453490 A AU5453490 A AU 5453490A AU 54534/90 A AU54534/90 A AU 54534/90A AU 5453490 A AU5453490 A AU 5453490A AU 5453490 A AU5453490 A AU 5453490A
Authority
AU
Australia
Prior art keywords
cyanocobalamin
therapeutic uses
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU54534/90A
Other versions
AU620512B2 (en
Inventor
Michael Arlington
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU5453490A publication Critical patent/AU5453490A/en
Application granted granted Critical
Publication of AU620512B2 publication Critical patent/AU620512B2/en
Assigned to Arlington, Eileen Alexis reassignment Arlington, Eileen Alexis Alteration of Name(s) in Register under S187 Assignors: Arlington, Michael
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU54534/90A 1989-05-02 1990-04-30 Therapeutic uses of cyanocobalamin Ceased AU620512B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ3998 1989-05-02
AUPJ399889 1989-05-02

Publications (2)

Publication Number Publication Date
AU5453490A true AU5453490A (en) 1990-11-08
AU620512B2 AU620512B2 (en) 1992-02-20

Family

ID=3773892

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54534/90A Ceased AU620512B2 (en) 1989-05-02 1990-04-30 Therapeutic uses of cyanocobalamin

Country Status (2)

Country Link
AU (1) AU620512B2 (en)
CA (1) CA2015749A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787527B1 (en) 1994-11-10 2004-09-07 Duke University Methods of preventing and treating HIV infection

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007087631A2 (en) * 2006-01-26 2007-08-02 Bebaas, Inc. Cobalamin compositions for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2534809B1 (en) * 1982-10-26 1985-06-28 Roussel Uclaf DRUG COMBINATION CONTAINING, AS ACTIVE INGREDIENTS, A CENTRAL ANALGESIC AND VITAMIN B 12 OR A DERIVATIVE THEREOF
AU587658B2 (en) * 1985-10-10 1989-08-24 Access Pharmaceuticals Australia Pty Limited Oral delivery of biologically active substances bound to vitamin b12, or analogues thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787527B1 (en) 1994-11-10 2004-09-07 Duke University Methods of preventing and treating HIV infection

Also Published As

Publication number Publication date
AU620512B2 (en) 1992-02-20
CA2015749A1 (en) 1990-11-02

Similar Documents

Publication Publication Date Title
AU6434390A (en) Treatment of ards
EP0432600A3 (en) Derivatives of 2-iminopyridine
AU1444488A (en) Therapeutic nucleosides
AU2297388A (en) Therapeutic agents
AU6386390A (en) Therapeutic necleosides
AU3604289A (en) Treatment of arthritis
AU613543B2 (en) Preparation of halofluorobenzenes
AU4918790A (en) Medicament
AU617210B2 (en) Therapeutic nucleosides
AU6660090A (en) Treatment of depression
AU4552389A (en) Preparation of n-acyl-aminomethylphosphonates
AU3553489A (en) Novel compounds and treatment
AU3836489A (en) Treatment of immunodeficiency
AU4060289A (en) Therapeutic agents
AU6414190A (en) Treatment of carbohydrates
AU1318588A (en) Therapeutic nucleosides
AU6357890A (en) Expression of alpha-macroglobulins
AU3187489A (en) Therapeutic agents
AU6594690A (en) Therapeutic agents
AU3723589A (en) Therapeutic composition
AU2789389A (en) Therapeutic garment
AU4205489A (en) Condom
AU5453490A (en) Therapeutic uses of cyanocobalamin
AU8055187A (en) Therapeutic agents
AU6618990A (en) Fracture orthosis